Intracellular signals are required to activate the leukocyte-specific adhesion receptor lymphocyte function-associated molecule-1 (LFA-1; CDlla/CD18) to bind its ligand, intracellular adhesion molecule-1 (ICAM-1). In this study, we investigated the role of the cytoskeleton in LFA-1 activation and demonstrate that filamentous actin (F-actin) can both enhance and inhibit LFA-1-mediated adhesion, depending on the distribution of LFA-1 on the cell surface. We observed that LFA-1 is already clustered on the cell surface of interleukin-2/phytohemagglutinin-activated lymphocytes. These cells bind strongly ICAM-1 and disruption of the actin cytoskeleton inhibits adhesion. In contrast to interleukin-2/phytohemagglutinin-activated peripheral blood lymphocytes, resting lympho cytes, which display a homogenous cell surface distribution of LFA-1, respond poorly to intracellular signals to bind ICAM-1, unless the actin cytoskeleton is disrupted. On resting peripheral blood lymphocytes, uncoupling of LFA-1 from the actin cytoskeleton induces clustering of LFA-1 and this, along with induction of a high-affinity form of LFA-1, via "inside-out" signaling, results in enhanced binding to ICAM-1, which is dependent on intact intermediate filaments, microtubules, and metabolic energy. We hypothesize that linkage of LFA-1 to cytoskeletal elements prevents movement of LFA-1 over the cell surface, thus inhibiting clustering and strong ligand binding. Release from these cytoskeletal elements allows lateral movement and activation of LFA-1, resulting in ligand binding and "outside-in" signaling, that subsequently stimulates actin polymer ization and stabilizes cell adhesion.
INTRODUCTION
The lymphocyte function-associated molecule-1 (LFA-1)1 is an adhesion receptor that belongs to the family of integrins (CD11/CD18). It consists of an a-chain and a ß-chain which are noncovalently linked (Kurzinger et ál., 1981). LFA-1 is a leukocyte-specific integrin expressed on the cell surface of most leuko cytes and coordinates distinct adhesive and signaling interaction in the immune system such as T cell-mediated killing, T helper cell and B cell responses, nat ural killer cell activity, monocyte-mediated antibody-1992). As shown for PMA, these intracellular signals result in LFA-1 adhesion receptors that have a 200-fold higher affinity for binding of ICAM-1 than of the non activated receptors (Lollo et al., 1993) . Consistent with this observation, PMA has been shown to increase the diffusion rate of LFA-1, according to the lack of cy toskeletal constraints on LFA-1 (Kucik et al, 1996) , suggesting that PMA activation causes a temporary dislodgment of LFA-1 from the cytoskeleton and thereby induces an active conformation (high-affinity state) of LFA-1. We previously demonstrated that LFA-1 can only significantly bind to ICAM-1 when it is expressed in clusters at the cell surface (van Kooyk et al, 1994). Clustering of integrin molecules is thought to enhance the avidity of integrin-ligand interaction (Figdor et aL, 1990 ; van Kooyk et al, 1994) . It has recently been suggested for <*IIbß3 that ligand binding can induce clustering of integrins (Fox et al, 1996) . We have demonstrated that a unique antibody NKI-L16, which recognizes a C a2*-dependent epitope on LFA-1, is only expressed by clustered LFA-1, and can therefore report the distribution of LFA-1 at the cell surface (Keizer et , we investigated the role of the cy toskeleton in the activation of LFA-1 when expressed in leukocytes and nonleukocytes. Therefore, w e inves tigated the distribution and the adhesive capacity of LFA-1 on different cell types in the presence or ab sence of affinity modulators of LFA-1 (PMA) and cy toskeletal inhibitors. Here, we demonstrate that dis ruption of the actin cytoskeleton can inhibit or induce LFA-l-mediated adhesion to ICAM-1, depending on the surface distribution of LFA-1 (clustered / dis persed), but independent of the cell type (leukocytes versus nonleukocytes).
MATERIALS AND METHODS

mAbs and Chemicals
The mAbs SPV-L7 (IgGl), NKÍ-L15 (rgG2a), and NKI-L16 (IgG2a) reactive with the a-chain of human LFA-1 (CDlla) were raised as described previously (Keizer et al, 1985 (Keizer et al, , 1988 . The nonblocking mAb TS2/4 (IgGl) reactive with the a-chain of human LFA-1 was kindly provided by Dr. E. Martz (Sanchez-Madrid et al, 1982) . The blocking mAb 60.3 against the /^-chain was kindly provided by Dr. Harlan (Beatty et ai., 1983) , and the anti-ßj mAb KIM185 (IgGl) was used to activate LFA-1 (Andrew et al, 1993) . Other reagents used were PMA (50 nM, Calbiochem, La Jolla, CA), deoxyglucose (50 mM, Sigma Chemical Co., St. Louis, MO), and sodiumazide (10 mM, Merck, Hohenbrunn, Germany) to deprive the cell from energy, acrylamide (4 mM, Bio-Rad Laboratories, Hercules, CA) to block intermediate filaments, and nocodazole (10 /xg/ml, Sigma Chemical Co.) to block microtubules.
Cells and Cell Lines
A homogenous population of highly purified resting T lymphocytes was isolated from buffy coats of healthy donors by centrifugal élutriation, as described previously (Figdor et al, 1981) . Activated T lymphocytes were prepared by culturing these cells with recombi nant interleukin-(IL) 2 (400 U/ml, Cetus Corp., Emeryville, CA) and phytohemagglutinin (PHA, 0.2 jxg/ml, Murex Diagnostics, Dartford, England) in Iscove's medium (Life Technologies, Paisley, Scotland) supplemented with 5% fetal calf serum (BioWhittaker, Verviers, Belgium) and 1 % antibiotics/antimycotics (Life Technol ogies) for 6 days.
L-LFA-1 and BLM-LFA-1 cells were obtained by transfection of the complete cDNA of a L (in pCDM8 ) and ß2 (in pRC-CMV con taining a neomycin resistance gene, Invitrogen Corporation, San Diego, CA) into mouse fibroblast L cells and human melanoma cells (BLM; Katano et al., 1984) by Ca2P 0 4 precipitation (calcium phos phate transfection system, Life Technologies). After 24 h, the cells were maintained in Iscove's medium containing 5% fetal calf serum, 1 % antibiotics/antimycotics, and the neomycin analogue, genetidn ( 2 m g/m l, Life Technologies). The different transfectants were sorted three times to obtain a homogenous population of cells 
Cell Adhesion Assays
Binding of LFA-1 -positive cells to ICAM-1 was performed using ICAM-1 fusion proteins consisting of the five domains of ICAM-1 fused to a human IgGl Fc fragment (ÏCAM-lFc 
Confocal Microscopy
Adherent cells were grown overnight (adherent cells: BLM and L cell transfectants) on glass slides and nonadherent cells [resting peripheral blood lymphocytes (PBLs) and activated PBLsl were immobilized on glass slides precoated with Celltak adhesive (Col laborative Biomedical Products, Bedford, MA). Cells were pre treated with cytochalasin D (5 fig/m l; 10 min at 3 7°C) and activated with PMA (50 nM) for 20 min at 37°C in the presence of cytochalasin D, followed by fixation with 0.5% paraformaldehyde. Fixed cells were stained with the mAb TS2/4 (10 /xg/ml) for 30 min at 37°C, followed by incubation with FITC-labeled goat (Fab') 2 anti-mouse IgG mAb for 30 min at room temperature. Cell surface distribution of integrins was determined by confocal laser scanning microscopy (CLSM) at 488 nm with a krypton/argon laser (Bio-Rad). In all experiments, the same instrument settings of the CLSM were used.
RESULTS
Expression of LFA-1 by L Cell Fibroblasts and BLM Melanoma Cells
To compare the function of LFA-1 in leukocytes with that in nonleukocytes, we generated transfectants in which both the a and ß subunit of LFA-1 were trans fected. We expressed LFA 
Dual Role of F-Actin in LFA-1-mediated Adhesion Is not Restricted to Leukocytes
To investigate whether the dual role of F-actin in regulating LFA-1 function is restricted to leukocytes, 2) In a large number of the studies, cell aggregation assays were used rather than adhesion assays to purify ICAM-1.
3) The distribution state of the inte grins on the cell surface was never investigated. We have demonstrated that coupling of LFA-1 to the actin cytoskeleton is independent of the cell type (leu kocytes compared with nonleukocytes). Furthermore, activation of LFA-1 and subsequent ligand binding depends both on the distribution and on the affinity state of the receptor. F-actin has dual functions: 1) to maintain LFA-1 molecules in a clustered form (IL-2/ PHA-activated PBLs; LFA-1/LI 6hl) and 2) to act as a repressor to hold LFA-1 molecules in an inactive form, distributed over the cell surface (resting PBLs; LFA-1/L1610). We hypothesize that these LFA-1 molecules can only become sensitive to "inside-out" activation when they are temporarily dislodged from the cy toskeleton. Leukocytes require mechanisms to regu late LFA-1 adhesion, since they should be able to circulate as nonadherent cells in blood and lymph and to migrate as adherent cells throughout the tissues. Detachment from and coupling to the actin cytoskel eton provides leukocytes with a mechanism to rapidly alter both the avidity and affinity of LFA-1 to respond to physiological stimuli occurring in vivo.
